Morningstar Research and Commentary

Novo Nordisk Earnings: Surge in Obesity Treatments Boosts Outlook

Improved guidance reflects stronger supply and demand for GLP-1 products in 2025.

Feb 9, 2025 - 23:49
 0
Novo Nordisk Earnings: Surge in Obesity Treatments Boosts Outlook
Improved guidance reflects stronger supply and demand for GLP-1 products in 2025.
Read More

Tags:

Previous Article

UK Investment Trusts vs Saba Capital: 6-0

Next Article

The 10 Best-Performing Eurozone Dividend Stocks of January 2025

Related Posts

BP Shares Soar on Talk of Activist Stake

BP Shares Soar on Talk of Activist Stake

Feb 10, 2025  0

Lessons For European ETF Investors From the DeepSeek AI Stock Selloff

Lessons For European ETF Investors From the DeepSeek AI...

Feb 9, 2025  0

Investment Trust Latest: Keystone Positive Change Moves Ahead with Restructuring

Investment Trust Latest: Keystone Positive Change Moves...

Feb 10, 2025  0